As of January 22, 2025, GH Research (GHRS) has a market cap of $0.46 billion USD. According to our data, GH Research is ranked No.6226 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.46 B |
25.71%
|
Dec 31, 2024 | $0.36 B |
20.69%
|
Dec 29, 2023 | $0.30 B |
-40.33%
|
Dec 30, 2022 | $0.51 B |
-58.34%
|
Dec 31, 2021 | $1.21 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
COMPASS Pathways
CMPS
|
$0.34 B |
-0.000 M
|
UK
|
Mind Medicine
MNMD
|
$0.51 B |
0.000 M
|
USA
|
Atai Life Sciences
ATAI
|
$0.26 B |
0.000 M
|
Germany
|
Cybin
CYBN
|
$0.20 B |
0.000 M
|
Canada
|
Seelos Therapeutics
SEEL
|
$0.21 M |
0.023 M
|
USA
|
Market Cap | = | GHRS Stock Price | * | GHRS Shares Outstanding |
= | $8.80 | * | 52.03 M | |
= | $0.46 B |